315 related articles for article (PubMed ID: 28923346)
1. Role of fibroblast growth factor receptors (FGFR) and FGFR like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and adipocytes.
Kähkönen TE; Ivaska KK; Jiang M; Büki KG; Väänänen HK; Härkönen PL
Mol Cell Endocrinol; 2018 Feb; 461():194-204. PubMed ID: 28923346
[TBL] [Abstract][Full Text] [Related]
2. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
3. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
Cornish EE; Natoli RC; Hendrickson A; Provis JM
Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptors in in vitro and in vivo chondrogenesis: relating tissue engineering using adult mesenchymal stem cells to embryonic development.
Hellingman CA; Koevoet W; Kops N; Farrell E; Jahr H; Liu W; Baatenburg de Jong RJ; Frenz DA; van Osch GJ
Tissue Eng Part A; 2010 Feb; 16(2):545-56. PubMed ID: 19728793
[TBL] [Abstract][Full Text] [Related]
5. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
Cells Tissues Organs; 2009; 189(1-4):93-7. PubMed ID: 18728353
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling.
Miraoui H; Oudina K; Petite H; Tanimoto Y; Moriyama K; Marie PJ
J Biol Chem; 2009 Feb; 284(8):4897-904. PubMed ID: 19117954
[TBL] [Abstract][Full Text] [Related]
7. Autocrine fibroblast growth factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells.
Hamidouche Z; Fromigué O; Nuber U; Vaudin P; Pages JC; Ebert R; Jakob F; Miraoui H; Marie PJ
J Cell Physiol; 2010 Aug; 224(2):509-15. PubMed ID: 20432451
[TBL] [Abstract][Full Text] [Related]
8. Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes.
Gharibi B; Abraham AA; Ham J; Evans BA
J Bone Miner Res; 2011 Sep; 26(9):2112-24. PubMed ID: 21590734
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1.
Amann R; Trueb B
Int J Mol Med; 2013 Nov; 32(5):983-8. PubMed ID: 24026051
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.
Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M
J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508
[TBL] [Abstract][Full Text] [Related]
11. The FGFRL1 receptor is shed from cell membranes, binds fibroblast growth factors (FGFs), and antagonizes FGF signaling in Xenopus embryos.
Steinberg F; Zhuang L; Beyeler M; Kälin RE; Mullis PE; Brändli AW; Trueb B
J Biol Chem; 2010 Jan; 285(3):2193-202. PubMed ID: 19920134
[TBL] [Abstract][Full Text] [Related]
12. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
Chen ZX; Chang M; Peng YL; Zhao L; Zhan YR; Wang LJ; Wang R
Regul Pept; 2007 Jul; 142(1-2):16-23. PubMed ID: 17331598
[TBL] [Abstract][Full Text] [Related]
13. β-catenin directly sequesters adipocytic and insulin sensitizing activities but not osteoblastic activity of PPARγ2 in marrow mesenchymal stem cells.
Rahman S; Czernik PJ; Lu Y; Lecka-Czernik B
PLoS One; 2012; 7(12):e51746. PubMed ID: 23272157
[TBL] [Abstract][Full Text] [Related]
14. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
Mansukhani A; Ambrosetti D; Holmes G; Cornivelli L; Basilico C
J Cell Biol; 2005 Mar; 168(7):1065-76. PubMed ID: 15781477
[TBL] [Abstract][Full Text] [Related]
15. Role of FGFRL1 and other FGF signaling proteins in early kidney development.
Trueb B; Amann R; Gerber SD
Cell Mol Life Sci; 2013 Jul; 70(14):2505-18. PubMed ID: 23112089
[TBL] [Abstract][Full Text] [Related]
16. Regulation of fibroblast growth factor 2 and fibroblast growth factor receptors by transforming growth factor beta in human osteoblastic MG-63 cells.
Sobue T; Gravely T; Hand A; Min YK; Pilbeam C; Raisz LG; Zhang X; Larocca D; Florkiewicz R; Hurley MM
J Bone Miner Res; 2002 Mar; 17(3):502-12. PubMed ID: 11874241
[TBL] [Abstract][Full Text] [Related]
17. MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis.
You L; Pan L; Chen L; Gu W; Chen J
Cell Physiol Biochem; 2016; 39(1):253-65. PubMed ID: 27337099
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels.
Lai WT; Krishnappa V; Phinney DG
Stem Cells; 2011 Jul; 29(7):1102-11. PubMed ID: 21608080
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factors 1 and 2 inhibit adipogenesis of human bone marrow stromal cells in 3D collagen gels.
Le Blanc S; Simann M; Jakob F; Schütze N; Schilling T
Exp Cell Res; 2015 Nov; 338(2):136-48. PubMed ID: 26384550
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
